The Centers for Medicare and Medicaid Services recently announced major price reductions for 15 widely prescribed medications, including popular drugs like Ozempic and Wegovy. These negotiated prices will take effect in 2027 and represent significant savings for both the Medicare program and the millions of patients who rely on these medications. For healthcare providers and […]
Calquence, CMS, Ibrance, Janumet, Medicare, Medicare Part D, Negotiated Prices, Ofev, Ozempic, Pomalyst, Rybelsus, Tradjenta, Wegovy, Xtandi
If you’re a healthcare provider or facility dealing with Medicare, one thing is certain, getting properly reimbursed is a maze filled with complex rules, convoluted paperwork, and often, sheer frustration. Medicare reimbursement is the lifeblood that keeps many healthcare operations afloat, but navigating its serpentine pathways can feel like a daily battle. Buckle up as […]
APC, APCs, CMS, Geographical Practice Cost Index, Healthcare, Healthcare Billing, Inpatient Prospective Payment System, IPPS, Medical, Medical Billing, Medicare, Medicare Billing, Medicare Part A, Medicare Part B, Medicare Part C, Medicare Part D, Medicare Physician Fee Schedule, Medicare Reimbursement, Medicare Severity Diagnosis Related Groups, MIPS, MS-DRG, OPPS, Prospective Payment Systems, Revenue Cycle, Revenue Cycle Management